ArticleBioengineering (Basel, Switzerland)2026
Intraocular Micro-LED Epiretinal Projection for Anterior Segment Blindness: Design and Large-Animal Feasibility Study.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Irreversible anterior segment blindness with preserved retinal integrity (e.g., dense corneal opacity) remains a major clinical challenge because effective sight-restoring options are limited. Here, we describe an intraocular micro-light-emitting diode (Micro-LED) epiretinal microdisplay intended to deliver patterned optical stimulation to intact photoreceptors by bypassing opaque anterior optics. The prototype was based on a color-capable VGA microdisplay (640 × 480 pixels) and operated at <30 mW under typical conditions. An ultra-thin flexible cable and a copper-mesh-reinforced polydimethylsiloxane (PDMS) encapsulation provided a compact, conformable intraocular package with high pixel density. We evaluated a monochromatic (green) prototype in a single beagle eye (n=1) using a transscleral implantation approach and performed 7 days of postoperative follow-up with slit-lamp examination and multimodal imaging. Patterned stimulation via the implanted display elicited flash-evoked visual evoked potentials (VEPs) with consistent within-session waveform morphology, providing preliminary neurophysiological surrogate evidence of upstream visual pathway activation under the tested conditions in this single-animal pilot. The short-term postoperative course included transient hypotony and anterior segment inflammation, and implant rotation with associated inferior retinal detachment was observed by day 7, highlighting current biomechanical limitations. Beyond anterior segment opacity, the same intraocular optical interface could be explored as a modular light-delivery platform to pair with emerging retinal therapies (e.g., optogenetics), pending chronic safety and functional validation. This pilot large-animal study therefore provides a translationally relevant testbed while delineating key engineering constraints that must be addressed next.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.